Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging
Nature Clinical Practice Cardiovascular Medicine · 2004
DOI: 10.1038/ncpcardio0013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Cardiovascular Medicine, 2004. Verfasst von Michael J Lipinski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zena and Michael A Wiener Cardiovascular Institute/Marie-Josée and Henry R Kravis Center for Cardiovascular Health. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zena and Michael A Wiener Cardiovascular Institute/Marie-Josée and Henry R Kravis Center for Cardiovascular Health.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Lipinski, M. J., Fuster, V., Fisher, E. A., & Fayad, Z. A. (2004). Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nature Clinical Practice Cardiovascular Medicine. https://doi.org/10.1038/ncpcardio0013
Vancouver
Lipinski MJ, Fuster V, Fisher EA, Fayad ZA. Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nature Clinical Practice Cardiovascular Medicine. 2004. doi:10.1038/ncpcardio0013
BibTeX
@article{Lipinski2004,
author = {Lipinski, Michael J and Fuster, Valentin and Fisher, Edward A and Fayad, Zahi A},
title = {Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging},
journal = {Nature Clinical Practice Cardiovascular Medicine},
year = {2004},
doi = {10.1038/ncpcardio0013}
}
EUVIMED